Send me more jobs like this

SAP QM Functional consultant

Keywords / Skills : QM Functional consultant, SAP MM Functional Consultant, SAP PP Module, SAP QM, GMP

5 - 7 years
Posted: 2019-04-11

Industry
Pharmaceutical
Function
IT
Role
ERP, CRM - Functional Consultant
Posted On
11th Apr 2019
Job Description
Error resolution:
  • Provide resolution for frequent errors arising in routine QM operations as well as incidents raised in SOLMAN; and follow through to resolution. 
  • Ensure adherence to the defined SLA along with identifying the process improvements. 
  • Coordinate with internal team to address / resolve cross-module issues 
  • Check and Record incidents and issues in tracking tool, 
Development of additional Functionality:
  • Identify the need of developments based on incidents; coordinate with internal team for solutioning 
  • Coordinate with internal teams for User Requirement Specification and Testing of developed functionality within closure timelines 
  • Coordinate with SAP Support team to follow up and close issues raised 
  • Arrange user training on periodic basis for existing and new functionalities; Create user manuals for routine processes that can be shared with new users 
  • Good functional knowledge of standard SAP MM, PP, and QM processes along with basic understanding of GMP required 
  • Core functional experience of SAP QM; 5-7 years 
  • Good knowledge of standard SAP PP, and MM processes 
  • Good understanding of GMP and other regulatory requirements 
  • Understanding of BADi, BAPI, BDC etc. 
  • Provide end user training on periodic basis related to Existing/new functionality in SAP. 


About Company

Biocon is Asia’s premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world.

We have evolved from manufacturing pharmaceuticals like statins and immunosuppresants, to discovering, developing and producing biologics in chronic therapies such as diabetes, oncology and immunology for global markets. This has translated into a diversified and differentiated pipeline of fermentation-derived complex generics, biosimilars that include insulins and monoclonal antibodies, and novel biologics.

Biocon is among the few companies globally to have received approvals for its biosimilars from developed countries like the U.S., EU, Australia and Japan. Our credibility as a serious player in the biosimilars sector was first established with the Japanese approval for Insulin Glargine. The credibility was enhanced when Biocon, along with partner Mylan, became the first globally to get biosimilar Trastuzumab and Pegfilgrastim approved in the U.S. in 2017 and 2018, respectively. We were also among the first few to receive Insulin Glargine approval in Europe and Australia for Insulin Glargine, both in partnership with Mylan. We have also established our presence in key emerging markets through safe, effective and high quality biosimilars including recombinant human insulin.

A combination of specialized talent, state-of-the-art research and manufacturing infrastructure and a culture of deep science and regulatory compliance have differentiated us in the marketplace and given us a distinct competitive edge. It has also led to Biocon being recognized as a credible global biopharmaceuticals player.
Similar Jobs
View All Similar Jobs
Walkin for you